We evaluate drug immunogenicity and its impact on PK and PD by measuring ADA levels with a tiered approach (screening assay followed by a confirmatory assay).
ADA Bioanalysis for Anti-HER2 Immunogenicity Assessment
ADA tested using screening assay, confirmatory assay and titer assay
ADA occurred in one animal after repeated IV dosing
